| Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study (NCT06991894) | Novartis Pharmaceuticals | 2021-07-14 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study (NCT03733249) | Bellicum Pharmaceuticals | 2017-01-01 |
| Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia (NCT02857530) | Tianjin Medical University General Hospital | 2016-08-01 |
| Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) (NCT02773225) | B. Höchsmann | 2015-01-27 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant (NCT03301168) | Bellicum Pharmaceuticals | 2014-04-01 |
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer (NCT00975975) | Indiana University | 2009-09-01 |
| Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States (NCT00997386) | University of Arizona | 2009-09-01 |
| Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment (NCT00944749) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-08-31 |
| A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients (NCT00922883) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-05-29 |
| Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors (NCT00618969) | University of Arizona | 2008-02-01 |
| Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia (NCT00578266) | Mayo Clinic | 2007-02-01 |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor (NCT00393380) | The Emmes Company, LLC | 2006-09-01 |
| Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia (NCT00319878) | Office of Rare Diseases (ORD) | 2006-05-01 |
| Identifying Characteristics of Bone Marrow Failure Syndromes (NCT00315419) | Office of Rare Diseases (ORD) | 2006-04-01 |
| Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA) (NCT00737685) | The Korean Society of Pediatric Hematology Oncology | 2006-01-01 |
| Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) (NCT00326417) | Medical College of Wisconsin | 2006-01-01 |
| Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias (NCT00244010) | St. Jude Children's Research Hospital | 2005-10-01 |
| Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia (NCT00229619) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-09-01 |
| Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias (NCT00061763) | Novartis Pharmaceuticals | 2003-05-01 |
| Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia (NCT00399971) | Shenzhen Zhongxing Yangfan Biotech Co. Ltd. | 2002-11-01 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00683046) | University of Chicago | 2001-11-01 |
| Cord Blood Stem Cell Transplantation Study (COBLT) (NCT00000603) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor (NCT00144729) | Fred Hutchinson Cancer Center | 1993-05-01 |
| Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data (NCT00005307) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-04-01 |
| Aplastic Anemia Epidemiology: Incidence and Case-control (NCT00005682) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-09-01 |
| Drug Etiology of Aplastic Anemia and Related Dyscrasias (NCT00005302) | National Heart, Lung, and Blood Institute (NHLBI) | 1985-04-01 |
| Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders (NCT00000597) | National Heart, Lung, and Blood Institute (NHLBI) | 1982-03-01 |